We Told You So !

Discussion in 'Acorda Therapeutics' started by anonymous, Dec 24, 2018 at 1:03 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    GO F OFF !!!!!! you moron ! ACOR will double by 1Q19 so CUT THE CRAP YOU A-HOLE !!! Our Leader will never sell out, but will hold the field team responsible for the success of inhaled LD
     

  2. anonymous

    anonymous Guest

    Your leader does not decide who they sell to... shareholders do. It’s called a proxy vote
     
  3. anonymous

    anonymous Guest


    Our Leader is highly regarded by the BOD, with a successful track record. Bumps on road due to some hacks who made idiotic decisions and were loose cannons. Furthermore our Leader has high share ownership himself as do his allies. He ultimately will call all the shots re ACOR. We are blessed this N Y Eve with a great Leader !!! 2019 should be a cakewalk after finally getting the inhaled LD approved and the international markets are anticipating strong demand. Buy ACOR now, another up day !!!
     
  4. anonymous

    anonymous Guest

    Unless accorda is going into battle.. allies don’t mean anything. Insider holdings for the stock is 2%. Hardly enough leverage to make a dent in a proxy vote for any unsolicited bid. Secondly, your leader was responsible for deliverables / or non deliverables while he was at the helm and he let these morons continue to collect a paycheck.....Stocks almost at a 2 yr low, even after fda approval. That alone should give any rationale individual insight to lack of street sentiment. Keep up the rah rah session, even if the stock doubled your still below a 52 week high. A neighborhood that will never be seen again. Told u so...
     
  5. anonymous

    anonymous Guest

    WTF are you talking about? Goldman just put a $10 PT on your stock. Moron.
     
  6. anonymous

    anonymous Guest

    The Wall Street pros know ACOR is solid that's why the strong 'Accumulate' recommendation. Our GL (Great Leader) has brought in the FDA approval ahead of schedule ! The Street predicted 1Q19. He did it in 2018 ! !
    As such growing confidence in ACOR with strong sales also expected in the Asian and European market for inhaled LD. Its now up to the field reps to do their job !!!

    Happy New Year !
     
  7. anonymous

    anonymous Guest

    Happy New Year Habib!

    VelociRon did not bring inhaled LD in ahead of schedule (of course you know this). Inhaled LD was late to file and recieved both a CRL and an extension. The FDA approved three weeks early which goes to their “on time” record not yours.

    You may want to review how NICE, IQWIG and other agencies view high priced, alternate delivery products ex US before you start counting your goats.

    Additionally, with a 60% + GTN to even play ball in the US, your revenues are going to take a heavy hit.

    Enjoy your spoils from shilling for VelociRon, you have earned it.
     
  8. anonymous

    anonymous Guest

    This place is a mess internally and in the field. There is a lack of communication and certainly execution! I am leaving this hell soon as many others have. Key people leaving? Know why?

    Yes - you trash people that have left or built this POS place because you are jealous. People are running from this hell. The Street says SELL SELL! The forecast is a lie like everything else. What a façade you have put up. SELL FINALLY RON! YOU CANNOT KEEP THIS CHARADE OF INEPTITUDE UP!
     
  9. anonymous

    anonymous Guest

    This place is horrible to work at! all BS lies on the surveys as people were afraid. RC? Looks down at people with that snide look. Pathetic. Sell this joint!
     
  10. anonymous

    anonymous Guest

    Race to the bottom... Q1 19 = <$9.... you will be lucky to have insurance coverage by Q1 2020. Even with your copay assistance your GTN will be pitiful and with alternative generic options MDs will be resistant to touch a new modality inside of first year, especially with delay of approval. I keep hearing ... launch flawlessly..... it’s hard to reproduce when it has never been accomplished.... the street has lost faith, your employee have lost faith with the double talk and rah rah / allies..... all internal mouthpiece bs smokescreen. Try and catch the falling knife of accorda without getting cut... We told you so.
     
  11. anonymous

    anonymous Guest

    I am amazed at the couple of #MAGA racists that keep posting negative BS about Acorda and its management.

    Now that the inhaled levodopa is approved, their new tune is that it won't sell, ect...

    Look "boys and girls", it is obvious from your posts that you don't hold a Columbia PhD; nor are analysts at Goldman-Sachs. Instead, by the sounds of your " quaking", you are nothing more than some ducks that at one point or another were let go of Acorda because of your ineptitude or destructive personalities.

    Acorda is now poised to recover nicely. This Team knows how to execute on sales for CNS specialty drugs.

    Granted, if I was in their BD Team and BoD, I be looking at generous offers to be acquired. Investors to DO WANT (and need) a return of their investment.

    Best of luck Acorda !
     
  12. anonymous

    anonymous Guest

    Time to depart this thread. You folks have a Scientologist mentality. Stock can’t do anything but recover from where you were.... similar to an individual investor who lost 60% in their portfolio in 2018..... but then touts they are up 10% YTD in 2019. Hope you prove market penetration and find a buyer. Best of luck
     
  13. anonymous

    anonymous Guest

    The previous posts are truly pathetic. Sore losers no doubt. Obfuscating the truth. Mere whimps. Incapable of critical thinking. We now have a winner product approved by FDA. We have a management team and field team highly motivated (yes job security is a motivator) and Was Street sees an uphill in ACOR. We have international market waiting for inhaled LD !! Get out there and do your job!! Our Leader is demanding no less!!! A Mensa genius!!
     
  14. anonymous

    anonymous Guest

    ANOTHER GREAT DAY !! ACOR bulldozed ahead 5.16% today !!!!! Thats 35% in just 9 trading days !!! Many of us who listened to the Wall Street pros an our leadership team are counting BIG BIG PROFITS over just 2 weeks !!! Made big bet and made enough to get that new Landcruiser my gal has lusted. Now thank you Dr RC ! We luv ya !!
     
  15. anonymous

    anonymous Guest

    Habib, even if you bought in on the low end and sold at the max, the sheer volume you would have to move to make any significant money on a three dollar market swing is beyond your abilities with the rupees VelociRon pays you.

    More likely is your “gal” is named Sanjeet and you will be rolling large in your parents minivan going to Aditi for a quick meal.

    You have been pumping every move on the stock since it was in the $20-$30 range. Either you are under water or full of crap. My guess is both.
     
  16. anonymous

    anonymous Guest

    My guess is he also bought in personal account and did not disclose to acorda legal. We know what that means...
     
  17. anonymous

    anonymous Guest

    You are such a #MAGA racist ! Let's call a Duck a Duck.

    (And BTW, I am a different poster who recognizes the rhetoric and naivete of some of the other posts. But racism is not part of my lexicon. Do CP a favor, move on.)
     
  18. anonymous

    anonymous Guest

    Who’s the brown ho mo above?
     
  19. anonymous

    anonymous Guest

    Spare me the faux outrage Habib.

    Spend more time researching your subject matter and less time blindly believing (or schilling for) VelociRon.

    As an aside, the only ones playing race and gender politics are your socialist brethren. Trump has done more for all minorities than any of your liberal icons.
     
  20. anonymous

    anonymous Guest

    Who is the idiot above?

    What an arse ...bigger hole than the Lincoln tunnel!!!